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Background and Objective: Coronavirus disease 2019 (COVID-19) characterized by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has created serious
concerns about its potential adverse effects. There are limited data on clinical,
radiological, and neonatal outcomes of pregnant women with COVID-19 pneumonia.
This study aimed to assess clinical manifestations and neonatal outcomes of pregnant
women with COVID-19.
Methods: We conducted a systematic article search of PubMed, EMBASE, Scopus,
Google Scholar, and Web of Science for studies that discussed pregnant patients with
confirmed COVID-19 between January 1, 2020, and April 20, 2020, with no restriction
on language. Articles were independently evaluated by two expert authors. We included
all retrospective studies that reported the clinical features and outcomes of pregnant
patients with COVID-19.
Results: Forty-seven articles were assessed for eligibility; 13 articles met the inclusion
criteria for the systematic review. Data is reported for 235 pregnant women with
COVID-19. The age range of patients was 25–40 years, and the gestational age ranged
from 8 to 40 weeks plus 6 days. Clinical characteristics were fever [138/235 (58.72%)],
cough [111/235 (47.23%)], and sore throat [21/235 (8.93%)]. One hundred fifty six out
of 235 (66.38%) pregnant women had cesarean section, and 79 (33.62%) had a vaginal
delivery. All the patients showed lung abnormalities in CT scan images, and none of
the patients died. Neutrophil cell count, C-reactive protein (CRP) concentration, ALT,
and AST were increased but lymphocyte count and albumin levels were decreased.
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Amniotic fluid, neonatal throat swab, and breastmilk samples were taken to test for
SARS-CoV-2 but all found negativ results. Recent published evidence showed the
possibility of vertical transmission up to 30%, and neonatal death up to 2.5%. Pre-
eclampsia, fetal distress, PROM, pre-mature delivery were the major complications of
pregnant women with COVID-19.
Conclusions: Our study findings show that the clinical, laboratory and radiological
characteristics of pregnant women with COVID-19 were similar to those of the general
populations. The possibility of vertical transmission cannot be ignored but C-section
should not be routinely recommended anymore according to latest evidences and, in any
case, decisions should be taken after proper discussion with the family. Future studies
are needed to confirm or refute these findings with a larger number of sample sizes and
a long-term follow-up period.
Keywords: coronavirus, COVID-19, pregnant women, SARS–CoV-2, CT-scan
INTRODUCTION
Coronavirus disease 2019 (COVID-19), a global health
emergency, poses a serious public health threat (1). Countries
are implementing public health measures such as effective
and efficient preventive and control strategies (lock-down,
social distancing, strict travel restriction, and shut down of
academic institutions) to combat the ongoing coronavirus
spread (2). Currently, there are no vaccines or direct-acting
antiviral medications available for the treatment of SARS-CoV-2
infection (3). The concern has also been raised because the
numbers of pregnant women with confirmed COVID-19 have
been increasing, and viral pneumonia is considered as one
of the main risk factors of severe illness, higher morbidity,
and mortality among pregnant women (4). Previously, both
severe acute respiratory syndrome coronavirus (SARS-CoV) and
Middle East respiratory syndrome coronavirus (MERS-CoV)
created severe complications in pregnant women (5, 6), and
the mortality rate of SARS-CoV infection was 25% in pregnant
women (4).
Several studies reported that maternal pneumonia is
responsible for unfavorable obstetrical outcomes such as the
pre-mature rupture of membranes (PROM), intrauterine fetal
demise (IUFD), intrauterine growth restriction (IUGR), and
neonatal death (6, 7). However, limited data exists for this
population with COVID-19; it is not even well-established
whether COVID-19 could transmit vertically and increase
the risk to the fetus and neonate. We, therefore, aimed to
summarize the epidemiological, clinical, laboratory, and
radiological manifestations, and neonatal outcomes of pregnant
women with COVID-19. This study highlighted the following
research questions: (a) What are the clinical, laboratory,
and radiological outcomes for the patients with COVID-
19? (b) Does COVID-19 vertically transmit from mother to
children? (c) Is COVID-19 an indication of cesarean section
delivery for pregnant women?, and d) Does COVID-19
create severe maternal and neonatal complications among
pregnant women?
METHODS
Databases and Search Strategy
We systematically searched for published articles presenting
data for pregnant patients with confirmed COVID-19 between
January 1, 2020, and April 20, 2020, with no restriction on
language. We searched the electronic databases such as PubMed,
EMBASE, Scopus, and Google Scholar using the following search
terms: “pregnant women or pregnant patients” and “COVID-
19” or “Coronavirus disease-19” or “SARS-CoV-2.” One author
initially conducted the relevant article search, which was later
on verified by another expert author. We further scrutinized
the reference lists from retrieved articles in order to find more
potential articles.
Eligibility Criteria
Eligibility was restricted to articles that examined the clinical
characteristics like signs and symptoms, and laboratory findings,
radiological features, and neonatal outcomes of pregnant women.
We excluded studies if they did not invest in the neonatal
outcome of pregnant patients with COVID-19. As for the study
design, retrospective studies including case-control, letter to the
editor, case study without any limitation of participants were
eligible for inclusion, while we excluded studies that were only
published in the form of abstracts or reviews.
Study Selection
Our two experts (MMI, TNP) of systematic review and meta-
analysis independently reviewed the titles and abstracts of the
retrieved articles. They selected the appropriate articles based
on the pre-specified selection criteria. Disagreements during this
stage were settled by further discussion with the main supervisor
(YCL). They also developed a data collection form to extract
relevant information from selected articles. Furthermore, they
checked retrieved articles duplication by comparing authors’
names, publication date, journal names, study design, and
participant’s sizes.









































TABLE 1 | Clinical features of 235 mothers with COVID-19 infection.
Chen Cao Chen Wang Yu Wu$ Li Chen* Liu Zhu Lee Yang Yang
Clinical characteristics
Age
Avg ± SD. 29.88 ±
4.83




30.9 ± 3.2 – 32 ± 5 30.7 ± 3.12 28 – 30.2 ± 2.3
Range 26–40 29–35 25–31 – 29–34 21–37 26–37 28–34 23–40 25–35 – – –
Epidemiologic history 9 (100%) 10 (100%) – 1 (100%) 7 (100%) 23 (100%) – – 1 (100%) – –
Complications
Influenza 1 (11.11%) – – – – – – – – – – – –
Gestational
hypertension
1 (11.11%) – – – – 4 (17.39%) 3 (18.75%) – – – – 2 (28.57%) –
Gestational diabetics – – 2 (40%) – – – 3 (18.75%) – – – – – –
Pre-eclampsia 1 (11.11%) 3 (30%) 1 (20%) – – – 1 (6.25%) – – – – 2 (28.57%) –
Fetal distress 2 (22.22%) 2 (20%) – – – – – – – – – – –
PROM 2 (22.22%) 4 (40%) – – – – 1 (6.25%) – – – – – –
Pre-mature – 3 (30%) – 1 (100%) – – 1 (6.25%) – – 3 (30%) – – –
Uterine scarring – – – – 3 (42.85%) – – – 6 (60%) – – –
Placental abruption – 1 (10%) – – – – – – 1 (10%) – – –
Hypothyroidism – 1 (10%) – – – 2 (8.70%) 2 (12.5%) – – – – – –
Anemia – 1 (10%) – – – – – – – – – – –
GDM – 1 (10%) – – – – – – – – – – –
Twins – 1 (10%) – – – – – – – – – – –
None 2 (22.22%) – 2 (20%) – 4 (57.15%) – – – – – – – –
Signs and symptoms
Fever on admission 7 (78%) 2 (20%) – – 7 (85.71%) 4 (17.4%) 4 (25.0%) 84 (75%) 13 (86.66%) 9 (90%) 1 (100%) 5 (71.42%) 2(15.4%)
Post-partum fever 6 (67%) 5 (50%) 5 (100%) – 7 (85.71%) – 8 (50.0%) – 1 (6.66%) 3 (30%) – – –
Myalgia 3 (33%) – – – – – – – 3 (20%) – – – –
Malaise 2 (22%) – – – – – – – – – – – –
Rigor – – – – – – – – – – – – –
Cough 4 (44%) 1 (10%) 1 (20%) – 1 (14.28%) 6 (26. 1%) – 82 (73%) 9 (60%) 5 (50%) 1 (100%) 1 (14.28%) –
Sputum – – 1 (20%) – – – – – – – – – –
Coryza – – 1 (20%) – – – – – – – – –
Dyspnea 1 (11%) – – – 1 (14.28%) – – 8 (7%) 1 (6.66%) – – – –
Sore throat 2 (22%) – – – – – – – 1 (6.66%) 1 (10%) 1 (100%) – –
Diarrhea 1 (11%) – – 1 (14.28%) – – 8 (7%) 1 (6.66%) 1 (10%) – 1 (14.28%) –
Chest pain – 1 (10%) – – – – – 20 (18%) – – – – –
Fatigue – 1 (10%) – – – – – 19 (17%) 4 (26.66%) – – – –
Delivery methods
C-section 9 (100%) 8 (80%) 2 (40%) 1 (100%) 7 (100%) 18 (90%) 14 (87.5%) 63 (93%)** 10 (90.90%) 7 (70%) 1 (100%) 7 (100%) –
























































































































































































































































































































































































































































































































































Primary outcome measures were clinical features and neonatal
outcomes of pregnant patients with SARS-CoV-2. Therefore, we
collected epidemiological data, clinical signs and symptoms such
as fever, cough, fatigue and diarrhea, laboratory results, chest
radiology and CT findings, delivery methods (cesarean section
or natural), neonates’ outcomes such as birth weight, clinical
symptoms, and Apgar score. The author’s name, publication date,
location, and the number of pregnant women and neonates were
also collected.
Statistical Analysis
Statistical analyses were conducted with Excel. We showed
continuous variables directly as a range and categorical variables
as a number (%).
RESULTS
The article search of the electronic databases extracted 237
articles. We excluded 190 articles after reviewing their titles
and abstracts because they did not fulfill the selection criteria.
A total of 47 articles went for full-text assessment, and we
further checked their bibliography in order to find additional
articles to include; however, no additional articles were found.
We further excluded 34 studies because 23 studies did not meet
in our inclusion criteria, 7 studies did not provide appropriate
characteristics of pregnant women, 3 studies were reviews, and
1 study was a duplicate. Finally, 13 studies were included in our
systematic review (8–20). The flow chart of our search strategy is
illustrated in Supplementary Figure 1.
Twelve studies reported the gestational age of the pregnancy,
and more than 95 percent of pregnant women were in their third
trimester. There were 156/235 (66.38%) pregnant women that
had a C-section delivery, and the patients’ age ranged from 25
to 40 years. The most common pregnancy complications were
gestational hypertension, pre-eclampsia, and PROM. However,
some pregnant women experienced anemia, GDM, uterine
scarring, or hypothyroidism. One hundred thirty eight out of
235 patients (58.72%) had a fever on admission, and 43 patients
(18.30%) had a post-partum fever. Other symptoms were also
observed in pregnant women. One hundred eleven patients had
a cough, 21 patients had a sore throat, and 20 patients had
fatigue. Furthermore, myalgia, malaise, rigor, sputum coryza, and
diarrhea were also seen in pregnant women with COVID-19
(Table 1).
Five studies reported the white blood cell count (WBC);
however, eight patients reported an elevated result. Data showed
that 58 pregnant women with COVID-19 pneumonia had
lymphopenia (<1·0 × 109 cells per L). Sixty-three patients
had elevated concentrations of CRP (>4 mg/L). Five had
increased concentrations of alanine aminotransferase (ALT),
4 had increased concentration of aspartate aminotransferase
(AST), and five had a higher level of alkaline phosphatase level
(APL) (Table 2). Moreover, 6 patients had increased lactate
dehydrogenase, and 46 patients experienced increased D-dimer
concentration (>0.5 ug/L). All patients were tested positive by
the confirmatory test (SARS-CoV-2 quantitative RT-PCR).









































TABLE 2 | Laboratory characteristics of 235 pregnant women with COVID−19.
Normal
range
Chen Cao Chen Wang Yu Wu $ Li Chen* Liu Zhu Lee Yang Yang
White blood cell
count
(× 109 cells per L)
3.5–9.5 7.79 ± 1.98
(2 patients,
22.22%)↑
8.93 ± 1.70 (3
patients, 30%)↑
11.22 ± 3.61 (3
patients, 60%)↑
N/A N/A N/A 8.6 ± 1.8 N/A N/A N/A N/A N/A 8.9 ± 1.5
Lymphocyte count
(× 109 cells per L)
1.1–3.2 1.18 ± 0.75
(5 patients,
55.56%)↓
1.13 ± 0.63 (6
patients, 60%)↓
0.92 ± 0.11 (4
patients, 80%)↓



















<4 18.61 ± 10.41 (7
patients, 77.77%)
↑
14.58 ± 22.17 (6
patients, 60%) ↑
32.28 ± 33.57 ↑ 19.6↑ 31.87 ±
11.71↑





N/A 1.5 N/A 3.7
(1.9–7.8)
Albumin (ALB), g/L 40–55 N/A N/A 31.26 ± 2.76↓ 24.6↓ 32.42 ±
1.53↓
N/A N/A N/A N/A N/A N/A N/A N/A
ALT (U/L) 0–35 253.77 ± 690 (3
patients, 33.33%)
↑
9.52 ± 4.13 10.26 ± 4.48 N/A (2 patients,
28.57%)↑
N/A 11.6 ± 5.0 N/A N/A N/A N/A N/A N/A
AST (U/L) 0–35 171 ± 410.12 (3
patients, 33.33%)
↑
17.91 ± 5.73 20.22 ± 7.49 N/A 1 patient,
14.28%)↑
N/A 16.3 ± 5.2 N/A N/A N/A N/A N/A N/A










N/A N/A N/A N/A N/A N/A N/A N/A
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FIGURE 1 | Chest CT scans of pregnant women with COVID-19: (A) bilateral lower lung cord, (B) a ground-glass nodule on the right upper lobe, (C) denser shadows
scattered on the right lower lobe, (D) a little patchy shadow on the dorsal side of bilateral lower lungs and a little pleural effusion, (E) patchy shadows on bilateral lungs
and a small amount of pleural effusion on both sides, (F) ground-glass density nodules on the left, (G) patches near the pleura, bilateral pleural effusion, and (H)
ground glass and patch shadows scattered on the bilateral lungs.
All the studies mentioned that pregnant women underwent
a pulmonary CT scan and showed abnormalities in different
degrees including ground-glass opacity, patch-like shadows, fiber
shadows, pleural effusion, and pleural thickening. There were
no differences between the pregnant and non-pregnant groups.
The involvement of lesions mostly was bilateral multi-lobe, and
there was the peripheral, random, and diffuse distribution of
pulmonary lesions (Figure 1). Each patient further went to a
CT scan examination 3–4 days after their first examination
during admission.
Our study shows no information about the fetus and neonatal
death. Even neonatal asphyxia was not reported. Twenty-five
newborns were pre-mature, and fifteen newborns reported a
low birth weight. The range of birthweights was 1,520–4,050 g.
However, the 1-min and 5-min Apgar scores were 7–10 and 8–
10, respectively (Table 3). There were two newborns that showed
turbidity of the amniotic fluid, and no baby died. Neonatal throat
swab and breastmilk samples were examined for the presence of
SARS-CoV-2 but all were negative.
DISCUSSION
Main Findings
This first comprehensive systematic review shows clinical,
laboratory, radiological features, and neonatal outcomes from
235 pregnant women diagnosed with COVID-19. The clinical
characteristics, laboratory, and radiological manifestations are
similar in pregnant women with SARS-CoV-2 infection when
compared with the non-pregnant or general population. In
terms of clinical characteristics, the most common signs and
symptoms of pregnant women were fever, fatigue, and cough.
However, diarrhea, myalgia, and shortness of breath were also
reported but to a lesser extent. Laboratory findings indicated
that pregnant women with COVID-19 experienced a reduction
of absolute lymphocyte counts and an increment of the CRP,
erythrocyte sedimentation rate (ESR), and D-dimer; however,
leucocytes were in normal range among those patients. When
it comes to intrauterine vertical transmission from mother
to children and neonatal deaths, no vertical transmission
and neonatal death were reported. One hundred fifty six
out of 235 pregnant had a cesarean (C-section). Severe pre-
eclampsia, a history of C-section, placenta abruption, twins’
pregnancy, and fetal distress were the main reasons for the
C-section. SARS-CoV-2 infections were not indications for a
C-section. However, panic regarding this novel disease might
lead to choosing a C-section, but this was not reported
or investigated.
Public Health Implications
Coronaviruses (CoVs) are a single positive-stranded RNA virus
that causes infection of humans (21). SARS-CoV-2 is one of
the coronavirus species that emerged in China and which has
rapidly spread throughout the world in 2020. The pandemic
of SARS-CoV-2 infection has already created public health
threats resulting in a significant proportion of deaths (22, 23).
Pregnant women are more susceptible to respiratory pathogens
and pneumonia and are at risk of adverse obstetrical outcomes









































TABLE 3 | Neonatal outcomes of 235 COVID-19 patients.
Chen Cao Chen Wang Yu Wu$ Li Chen* Liu Zhu Lee Yang Yang
Gestational age
Range (week, day) 36–39+4 33+6-40+6 38+6-40+4 30 37–41+2 8–40 38 ± 0.2 N/A N/A 31–38+4 37+6 36–38+2 38.2 ± 2.3
Birthweight (g)















Range 1,880–3,730 2,050–3,800 3,235–4,050 – 3,000–3,500 – N/A – N/A 1,520–3,800 – 1,880–3,800 N/A
Low birthweight
(<2,500 g)
2 1 0 1 0 – 3 N/A N/A 7 0 1 N/A
Pre-mature delivery 4 3 0 0 0 – 4 14/68 N/A 0 0 0 N/A
Apgar score
(1min, 5min)
Range 8–9 & 9–10 8–9 & 10 10 &10 – 8 & 10 – – N/A 8 & 9 7–10 & 8–10 9 & 10 8–9 & 9–10 N/A
Avg. ± SD 8.71 ± 0.48 &
9.71 ± 0.48
8.6 ± 0.53 &
10 ± 0
10 ± 0 &
10 ± 0
– 8 &10 – 9.6 ± 0.5 &
10.0 ± 0.0
N/A 8 & 9 8.6 ± 0.75 &
9.4 ± 0.89





No No N/A N/A No – N/A No No No N/A N/A N/A
Amniotic fluid N/A Clear: 8,
turbidity: 2
N/A N/A N/A – N/A N/A N/A N/A N/A Negative: 5 N/A
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TABLE 4 | Basic characteristics, findings and suggestions from recent literatures.








Systematic review 74 PW = N/A;
N = 176
Infections mainly occur postnatally
through environmental exposure.
However, vertical transmission might
be occurred in ∼30% of neonates.
Following hygiene advice and proper
use of personal protective equipment
is important to reduce the risk of
transmission.
Akhtar et al. (40) Systematic review 22 PW = 156;
N = 108
Increased risk in pregnancy
complications such as pre-term birth,
PPROM, and may possibly lead to
maternal death in rare cases. No
evidence of vertical transmission.
Appropriate caution should be taken
and further investigate and monitor
possible infection in the neonates
born to COVID-19–infected mothers.
Chamseddine
et al. (42)
Systematic review 48 PW = 248,
N = 201
There are no evidence of vertical
transmission; although, some
neonates were tested positive. It can
be happened in the hospital or at
home environment after birth.
Strictly follow guidelines.
Gao et al. (43) Systematic review
and meta–analysis
24 PW = 236 No evidence that COVID-19 can
spread through vertical transmission.
Vertical transmission is possible in
patients with their first or second
trimester or where long–delivery
interval. Therefore, pregnant women
remain alert for the possibility of
vertical transmission.
Gatta et al. (44) Systematic review 6 PW = 51; N = 48 COVID-19 was associated with
increased risk of respiratory
insufficiency in late pregnancies.
However, there is no strong evidence
for vertical transmission.
Future studies are warranted to
provide a detail information on
maternal and fetal conditions, as well
as the rationale for obstetrical
interventions.
Khalil et al. (45) Systematic review
and meta–analysis
86 PW = 2,567 COVID-19 was associated with an
increased risk of iatrogenic pre-term
birth and cesarean delivery. Vertical
transmission probably occurs in
neonates.
Comprehensive assessment is
required to support or refute the risk
of vertical transmission.
Smith et al. (46) Systematic review 9 PW = 92; N = 37 COVID-19 was associated with
increased risk of pre-term births, low
birth weight, C-section. The evidence
of vertical transmission is vague.
A multidisciplinary approach is
recommended to monitor patients.
Lopes de Sousa
et al. (47)
Systematic review 49 PW = 755;
N = 598
SARS–CoV−2 may be associated
with several pregnancy complications.
However, there is no potential
evidence of vertical transmission
Recommend a comprehensive
monitoring and test pregnant women
before deliver or first contact with
newborn.
Di Toro et al. (51) Systematic review
and meta–analysis
24 PW = 1,104,
N = 444
COVID-19 did not significantly
influence the Pregnancy. Although,
higher rate of C-section had been
reported but there was no link to their
association. Furthermore, no clear
evidence of vertical transmission.
Pregnant women with COVID-19
should not be taken to C-section
irrationally. More studies are needed
to confirm possible risk of pregnant
women with SARS–CoV−2 infection.
Trocado et al. (48) Systematic review 8 PW = 95; N = 51 Pregnant women were more
susceptible to SARS–CoV−2
infection and faced several
complication. Moreover, vertical
transmission to neonate cannot be
ignored.
More researches are warranted to get
clear information about the impact of
COVID−19 in pregnant women.
Turan et al. (49) Systematic review 63 PW = 637;
N = 318
COVID-19 was associated with poor
maternal and neonatal outcomes.
Vertical transmission can be occurred
but there is no clear evidence.
Counseling is needed to the pregnant
women with COVID−19.
(Continued)
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TABLE 4 | Continued






Yee et al. (50) Systematic review
and meta-analysis
11 PW = 9,032;
N = 338
SARS-CoV-2 infection may increase
several complications among
pregnant women including neonatal
death. The possibility of vertical
transmission to neonates can be
ruled out.
More studies are needed to confirm




Systematic review 18 PW = 108 COVID-19 was associated with an
increased rate of poor neonatal
outcomes. The possibility of vertical
transmission cannot be ignored.
Careful monitoring and
measurements are needed to reduce
the fatal rate.
PW, Pregnant women; N, Neonate.
like the pre-mature rupture of membranes (PROM), pre-
term labor (PTL), and neonatal death. This is due to the
immunosuppressive state as well as physiological differences
(e.g., diaphragm elevation, increased oxygen consumption, and
oedema of respiratory tract mucosa) which often leads to severe
hypoxia (24, 25). Previous studies reported that the mortality
rate for pregnant women with influenza (1918–1919 pandemic)
was 37%; the rate of mortality was even higher (∼50%) in
patients who were in their 3rd-trimester of pregnancy (26).
During the 1957–1958 Asian flu epidemic, pregnant women
experienced a mortality rate of 10% which was 2-fold than
that of non-pregnant women (27). Moreover, SARS and MERS
were found to be associated with spontaneous miscarriages and
maternal death (4, 28). Nearly 50% of pregnant women with
SARS-CoV were admitted to the intensive care unit (ICU),
and among them one-third required mechanical ventilation,
and ∼25% of patients died who admitted to ICU, or required
mechanical ventilation (4). Approximately 57% of pregnant
women with SARS-CoV who were in their first trimester
experienced spontaneous miscarriages, and 80% of patients
with late pregnancy had preterm deliveries. Approximately
80% of patients had an emergency cesarean due to inadequate
maintenance of blood oxygen saturation, despite being on 100%
oxygen (29). Limited data are available for pregnant women
with MERS-CoV infection. Alfaraj et al. mentioned that the case
fatality rate (CFR) of pregnant women with MERS-CoV was 27%
but that was not significantly different when compared with the
overall CFR of MERS-CoV in the general population (35%) (30).
Guan et al. (31) reported a 1.4% mortality rate of pregnant
women with COVID-19. According to our study findings,
pregnancy complications, fetal and neonatal outcomes of
pregnant women with SARS-CoV-2 are much better than those
of SARS-CoV and MERS-CoV. All the babies who tested for
SARS-CoV-2 were negative; therefore, findings of our study do
not support the possibility of vertical transmission of SARS-
CoV-2 infection. Previous studies also showed that pregnant
women with SARS infection had not experienced any vertical
transmission from the mother to the newborn baby (4, 32). More
attention must be paid to pregnant women because it has been
reported that SARS-CoV-2 infection is linked to a cytokine storm
(33) (elevated plasma concentrations of interleukins 2 (IL-2),
IL-7, IL-10, interferon-γ-inducible protein 10 (IP-10, CXCL10),
monocyte chemoattractant protein 1, macrophage inflammatory
protein 1 alpha, and tumor necrosis factor α (TNF-α) that may
lead to undesirable outcomes in pregnant women, especially
in their first and third trimester as well as neonates. Maternal
inflammation during pregnancy is also associated with fetal
brain development and may lead to neuronal dysfunctions and
behavioral phenotypes (34). Our study reported common signs
and symptoms of pregnant women with COVID-19 which could
increase attention-deficit/hyperactivity disorder in the newborn
baby (35).
CT scan imaging is found to be an effective strategy to
identify asymptomatic pregnant women with COVID-19 early
as it shows the abnormality in patients (9). Timely identification
and intervention of patients can reduce obstetrical complications
such as miscarriage, intrauterine growth restriction, and pre-
term delivery, and improve pregnancy outcomes. Symptomatic
patients need to be admitted to a hospital quickly and isolated
in the intensive care unit with a negative pressure room (36).
In the process of fetal monitoring, regular fetal heart rate
should be monitored electronically to assess the fetal status
dependent upon the gestational age. Our study findings also show
that there is no association between COVID-19 and pregnancy
termination; therefore, a decision regarding the delivery process
must be individualized. Patients with mild symptoms should
be treated with the available treatment options and monitored
until the condition has improved. However, patients with critical
conditions or chance to intrauterine fetal demise or loss of both
mother and baby should be warranted.
Strengths
This current systematic review has several strengths. First, 13
studies with 235 patients COVID-19 were included in this
study. The inclusion of a large number of pregnant women will
help to get a more comprehensive understanding of COVID-
19 in pregnancy. Second, COVID-19 may increase the risk
of mother-to-child intrapartum transmission, but our findings
so far show no possibility of intrapartum transmission. Third,
this study presents clinical characteristics and maternal and
fetal outcomes of COVID-19 in late pregnancy from different
country’s perspectives.









































TABLE 5 | Pregnant women and neonatal outcomes compression among recent literatures.
Author Pregnant women Neonatal outcome














































N/A 6.9% 6.1% 35.3% N/A N/A N/A 6.5% N/A N/A 201 (89%) N/A N/A Yes Yes 2.5%
Gao et al. (43) N/A N/A N/A 29% N/A N/A N/A N/A N/A N/A 65% N/A N/A N/A No N/A
Della Gatta
et al. (44)
Yes N/A Yes N/A 26% Yes N/A N/A N/A N/A Yes N/A N/A Yes No N/A
Khalil et al. (45) N/A N/A N/A 6.30% N/A Yes N/A N/A N/A N/A 390
(52.31%)













N/A N/A N/A N/A N/A 20% N/A N/A N/A N/A 379 (65%) N/A N/A Yes Yes (2%) Yes (10 out
of 598)
Di Toro et al.
(51)
N/A N/A 7% N/A 10% 23% N/A N/A N/A N/A 713 (85%) 686 (14%) N/A N/A Yes (2%) N/A
Trocado et al.
(47)
Yes Yes 1% N/A N/A N/A N/A N/A N/A N/A 47 (94%) 3 (6%) 2,292.53 g N/A Yes (2%) Yes (1 out
of 48)
Turan et al. (49) Yes Yes N/A 46.7% N/A Yes N/A N/A N/A N/A 403
(84.1%)
76 (15.9%) N/A Yes Yes (2%) Yes (5 out
of 479)
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Comparison With Recent Findings
The findings and knowledge gained from our study suggests
that pregnant women are particularly susceptible to poor
outcomes and there was no evidence of vertical transmission
and C-section. Since, several articles have reported that the
possibilities of vertical transmission (37, 38), highlighting the
importance of long-follow up of newborns (39). To clarify
the vertical transmission and neonatal outcomes due to SARS-
CoV-2 infection; we further compared our findings with other
recently published systematic review and meta-analyses (38, 40–
50). Raschetti et al. (38) evaluated neonatal outcomes from 74
published articles in where 30% of neonates were reported in the
possible vertical transmission and 70% were from environmental
sources (Table 4). It is just possible that we cannot eliminate
but controversy still is going on whether SARS-CoV-2 infection
transmits from the mother to the fetus. However, the most
common complications of pregnant women were pre-eclampsia,
fetal distress, and PROM. Majority of pregnant women went for
C-section but there is no relation between COVID-19 infections
or vertical transmission and C-section (Table 5). Chest computed
tomography (CT) is the imaging is now being considered as
primary option for diagnosing COVID-19 in pregnant women
because it help to diagnosis disease in an early stage (52). Chest
computed tomography (CT) is considered as gold standard and
the performance is higher than that of the reverse transcription
polymerase chain reaction for disease diagnosis (53). Lung
ultrasound (LUS), a radiation-free point-of-care diagnostic tool,
has now been suggested as an accurate tool to detect COVID-19
because LUS is more sensitive to detect COVID-19 than that of
chest X-ray (54). Our study is different from other studies because
we have reported comprehensive clinical features, laboratory
findings, and neonatal outcomes. Our study findings and findings
from recently published systematic reviews may assist clinicians
to understand the nature of the disease, and to make appropriate
decisions when treating pregnant women with COVID-19.
Conclusion
This study shows that the clinical characteristics of pregnant
women with COVID-19 were varied, with the main signs and
symptoms being fever, cough, and sore throat. Conducting a
CT scan would be helpful to classify as early or progressive
stages, especially in asymptomatic patients, and can thus reduce
transmission. As pregnant women are susceptible to COVID-
19, lymphocyte count, CRP, albumin, and D-diameter could thus
be primary indicators for pregnant women with COVID-19.
Recent evidence suggests that there is a possibility of vertically
transmission from infected pregnant mothers to their fetuses.
C-section should not be routinely recommended anymore
according to latest evidences and, in any case, decisions should
be taken after proper discussion with the family. Further studies
are needed to confirm long-term outcomes and potential mother-
to-child vertical transmission with higher sample sizes.
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